These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 19067714)

  • 1. A clinical trial and molecular study of photoadaptation in vitiligo.
    Hexsel CL; Mahmoud BH; Mitchell D; Rivard J; Owen M; Strickland FM; Lim HW; Hamzavi I
    Br J Dermatol; 2009 Mar; 160(3):534-9. PubMed ID: 19067714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Photoadaptation of vitiliginous skin to targeted ultraviolet B phototherapy.
    Rivard J; Hexsel C; Owen M; Strickland FM; Lim HW; Hamzavi I
    Photodermatol Photoimmunol Photomed; 2007 Dec; 23(6):258-60. PubMed ID: 17986064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and Spectrophotometric Evaluation of Skin Photoadaptation in Vitiligo Patients after a Short Cycle of NB-UVB Phototherapy.
    Arisi M; Rossi MT; Fusano M; Gualini A; Tomasi C; Moggio E; Caravello S; Calzavara-Pinton P; Venturini M
    Dermatology; 2019; 235(6):509-515. PubMed ID: 31586997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of cutaneous photoadaptation to narrowband ultraviolet B.
    Darné S; Stewart LC; Farr PM; Hampton PJ
    Br J Dermatol; 2014 Feb; 170(2):392-7. PubMed ID: 24125495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tacalcitol and narrow-band phototherapy in patients with vitiligo.
    Leone G; Pacifico A; Iacovelli P; Paro Vidolin A; Picardo M
    Clin Exp Dermatol; 2006 Mar; 31(2):200-5. PubMed ID: 16487090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of a semiautomated method of minimal erythema dose testing for narrowband ultraviolet B phototherapy.
    Otman SG; Edwards C; Gambles B; Anstey AV
    Br J Dermatol; 2006 Aug; 155(2):416-21. PubMed ID: 16882183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted broadband ultraviolet b phototherapy produces similar responses to targeted narrowband ultraviolet B phototherapy for vitiligo: a randomized, double-blind study.
    Asawanonda P; Kijluakiat J; Korkij W; Sindhupak W
    Acta Derm Venereol; 2008; 88(4):376-81. PubMed ID: 18709309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal weekly frequency of 308-nm excimer laser treatment in vitiligo patients.
    Hofer A; Hassan AS; Legat FJ; Kerl H; Wolf P
    Br J Dermatol; 2005 May; 152(5):981-5. PubMed ID: 15888156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized double-blind trial of treatment of vitiligo: efficacy of psoralen-UV-A therapy vs Narrowband-UV-B therapy.
    Yones SS; Palmer RA; Garibaldinos TM; Hawk JL
    Arch Dermatol; 2007 May; 143(5):578-84. PubMed ID: 17519217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of vitiligo vulgaris with narrow-band UVB and oral Polypodium leucotomos extract: a randomized double-blind placebo-controlled study.
    Middelkamp-Hup MA; Bos JD; Rius-Diaz F; Gonzalez S; Westerhof W
    J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):942-50. PubMed ID: 17659004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Phototherapy with UV-B in vitiligo].
    Köster W; Wiskemann A
    Z Hautkr; 1990 Nov; 65(11):1022-4, 1029. PubMed ID: 2080652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical calcipotriene and narrowband ultraviolet B in the treatment of vitiligo.
    Kullavanijaya P; Lim HW
    Photodermatol Photoimmunol Photomed; 2004 Oct; 20(5):248-51. PubMed ID: 15379875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aged human skin removes UVB-induced pyrimidine dimers from the epidermis more slowly than younger adult skin in vivo.
    Yamada M; Udono MU; Hori M; Hirose R; Sato S; Mori T; Nikaido O
    Arch Dermatol Res; 2006 Jan; 297(7):294-302. PubMed ID: 16328344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy of pimecrolimus 1% cream plus narrow-band ultraviolet B in the treatment of vitiligo: a double-blind, placebo-controlled clinical trial.
    Esfandiarpour I; Ekhlasi A; Farajzadeh S; Shamsadini S
    J Dermatolog Treat; 2009; 20(1):14-8. PubMed ID: 18608735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of vitiligo with broadband ultraviolet B and vitamins.
    Don P; Iuga A; Dacko A; Hardick K
    Int J Dermatol; 2006 Jan; 45(1):63-5. PubMed ID: 16426381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison between 308-nm monochromatic excimer light and narrowband UVB phototherapy (311-313 nm) in the treatment of vitiligo--a multicentre controlled study.
    Casacci M; Thomas P; Pacifico A; Bonnevalle A; Paro Vidolin A; Leone G
    J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):956-63. PubMed ID: 17659006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antioxidants and narrow band-UVB in the treatment of vitiligo: a double-blind placebo controlled trial.
    Dell'Anna ML; Mastrofrancesco A; Sala R; Venturini M; Ottaviani M; Vidolin AP; Leone G; Calzavara PG; Westerhof W; Picardo M
    Clin Exp Dermatol; 2007 Nov; 32(6):631-6. PubMed ID: 17953631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of localized vitiligo with targeted broadband UVB phototherapy: a pilot study.
    Asawanonda P; Charoenlap M; Korkij W
    Photodermatol Photoimmunol Photomed; 2006 Jun; 22(3):133-6. PubMed ID: 16719866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the effects of NB-UVB in both segmental and non-segmental vitiligo affecting different body sites.
    Anbar TS; Westerhof W; Abdel-Rahman AT; El-Khayyat MA
    Photodermatol Photoimmunol Photomed; 2006 Jun; 22(3):157-63. PubMed ID: 16719871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Narrow-band ultraviolet B is a useful and well-tolerated treatment for vitiligo.
    Scherschun L; Kim JJ; Lim HW
    J Am Acad Dermatol; 2001 Jun; 44(6):999-1003. PubMed ID: 11369913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.